Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic phenotyping for monitoring ovarian cancer patients.

Scientific reports - 21 Mar 2016

Ke Chaofu, Li Ang, Hou Yan, Sun Meng, Yang Kai, Cheng Jinlong, Wang Jingtao, Ge Tingting, Zhang Fan, Li Qiang, Li Junnan, Wu Ying, Lou Ge, Li Kang

Abstract excerpt

Epithelial ovarian cancer (EOC) is the most deadly of the gynecological cancers. New approaches and better tools for monitoring treatment efficacy and disease progression of EOC are required. In this study, metabolomics using rapid resolution liquid chromatography mass spectrometry was applied to a systematic investigation of metabolic changes in response to advanced EOC, surgery and recurrence. The results...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Ovarian Epithelial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Metabolomics

Share to Neoplasms, Glandular and Epithelial

Share to Ovarian Neoplasms

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 26996990
DOI: 10.1038/srep23334
PMCID: PMC4800393

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic phenotyping for monitoring ovarian cancer patients.PMID 26996990Read ↗

SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study.Semantic proximity Read ↗

Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial CancerSemantic proximity Read ↗

Epithelial Ovarian Cancer: Disease Etiology, Treatment, Detection, and Investigational Gene, Metabolite, and Protein BiomarkersSemantic proximity Read ↗

Metabonomic analysis of follicular fluid in patients with diminished ovarian reserveSemantic proximity Read ↗

Untargeted metabolomics reveals homogeneity and heterogeneity between physiological and pathological ovarian agingSemantic proximity Read ↗

A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical CancerSemantic proximity Read ↗

Cancer metabolomicsSemantic proximity Read ↗

Integrated UPLC-MS/MS Metabolomics Reveals Novel Metabolic Markers for Type I Endometrial Carcinogenesis in Clinical SamplesSemantic proximity Read ↗

An overview of biomarkers for the ovarian cancer diagnosis.Semantic proximity Read ↗

A Metabolic Fingerprint of Ovarian Cancer: A Novel Diagnostic Strategy Employing Plasma Exosome-Based Metabolomics and Machine Learning AlgorithmsSemantic proximity Read ↗

Identification and validation of a prognostic index based on a metabolic-genomic landscape analysis of ovarian cancerSemantic proximity Read ↗

Metabolic molecular subtyping of ovarian cancer reveals the role of oleic acid-CD36 in facilitating cisplatin resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.